The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer

Brain metastases are usual in non-small-cell lung cancer (NSCLC) with poor prognosis and few available therapeutic options. This retrospective study aims to evaluate the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) against brain metastases from NSCLC harboring...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Hao, Xiong, Liwen, Han, Baohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415007/
https://www.ncbi.nlm.nih.gov/pubmed/28490892
http://dx.doi.org/10.2147/OTT.S129809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415007/
https://www.ncbi.nlm.nih.gov/pubmed/28490892
http://dx.doi.org/10.2147/OTT.S129809

Ejemplares similares